CTOs on the Move

Health Access Solutions

www.healthaccesssolutions.com

 
Health Access Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Foster City, CA. To find more information about Health Access Solutions, please visit www.healthaccesssolutions.com
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Chris Campbell
Director of Information Technology Profile

Similar Companies

AllTech Medical Systems

AllTech Medical Systems is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SoftScript

SoftScript is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SNBL Clinical Pharmacology Center

SNBL Clinical Pharmacology Center is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioStorage Technologies Inc

BioStorage Technologies Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.